deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04259203

Efficacy of Ericksonian Hypnosis in the Management of Chronic Pain Related to Parkinson's Disease (DOLHYP-PARK-1)

Sponsor: France Parkinson Association

Interventions Erickson hypnosis
Updated 7 times since 2020 Last updated: Dec 4, 2025 Started: Aug 8, 2020 Primary completion: Aug 16, 2024 Completion: Aug 16, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Chronic Pain and Parkinson Disease, this trial is completed. The trial is conducted by France Parkinson Association and has accumulated 7 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Jun 2022 · 14 months · monthly snapshotRecruiting~Jun 2022 – ~Jul 2024 · 25 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshotUnknown~Jan 2026 – present · 6 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Jan 2026 — Present [monthly]

    Completed NA

    Status: UnknownCompleted

  2. Sep 2024 — Jan 2026 [monthly]

    Unknown NA

    Status: RecruitingUnknown

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  4. Jun 2022 — Jul 2024 [monthly]

    Recruiting NA

  5. Apr 2021 — Jun 2022 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

Show 2 earlier versions
  1. Jan 2021 — Apr 2021 [monthly]

    Not Yet Recruiting NA

  2. Mar 2020 — Jan 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • France Parkinson Association
  • University Hospital, Lille
Data source: University Hospital, Lille

For direct contact, visit the study record on ClinicalTrials.gov .